← Leaderboards
Timothy A Benke
Baylor College Of Medicine
$7,331,995
Attributed
$12,969,589
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,969,589 · 10
By mechanism
U01$4,693,682 · 1
R01$1,637,612 · 1
K12$1,322,010 · 1
U24$1,273,996 · 1
U10$1,213,994 · 1
R21$862,488 · 2
Top collaborators
- Jenny Downs7 shared
- Helen M Leonard7 shared
- Eric D Marsh7 shared
- Amy R. Brooks-Kayal5 shared
- Timothy Lee Vollmer4 shared
- Jeffrey L Bennett3 shared
- Amanda L Piquet3 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Kimberly R Tolias$13,974,787
- Jianrong Tang$3,274,720
- Tamer M A Mohamed$5,113,243
- Daniel None Medina$5,636,236
- Bill R Brinkley$3,200,998
Others in their field
Top investigators on “Epilepsy”
- Karen Wilcox · University Of Utah$40,784,208
- Mark J Daly · Broad Institute, Inc.$39,233,325
- Wayne N. Frankel · Jackson Laboratory$37,394,025
- Shlomo Shinnar · Montefiore Medical Center (Bronx, Ny)$34,999,274
- Christopher A Walsh · Beth Israel Deaconess Medical Center$34,874,606
- Stacey Gabriel · Massachusetts Institute Of Technology$34,637,180
Research focus
EpilepsyBehavioralGeneticTrainingProgramsBaseElectroencephalographyNervous System DisorderResearch PersonnelNeurosciencesClinical ResearchPhenotypeRattusStructureChildhoodCognitiveAdultNovel TherapeuticsSynapsesMeasurementSeizuresColoradoFacultyCommunities
Grant awards (39)
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$782,432
U01 · FY2025 · NS · contact PI
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.$428,955
U24 · FY2025 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder - Supplement$77,998
U01 · FY2025 · NS · contact PI
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$859,629
U01 · FY2024 · NS · contact PI
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.$416,086
U24 · FY2024 · NS
Multi-site validation of biomarkers and core clinical outcome measures for clinical trial readiness in CDKL5 Deficiency Disorder$78,000
U01 · FY2024 · NS · contact PI
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$902,257
U01 · FY2023 · NS · contact PI
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.$428,955
U24 · FY2023 · NS
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$924,239
U01 · FY2022 · NS · contact PI
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder$1,069,127
U01 · FY2021 · NS · contact PI
Pilot studies to characterize CDKL5 inhibitors$443,988
R21 · FY2020 · NS · contact PI
Core C: Neural & Behavioral Phenotyping$187,698
P30 · FY2019 · NS · contact PI
Colorado Neurological Sciences Academic Development Award (NSADA)$151,690
K12 · FY2019 · NS
Colorado Neurological Sciences Academic Development Award (NSADA)$292,580
K12 · FY2018 · NS
Exploratory determination of the role of L-type calcium channels in mediating abnormal plasticity and behavior after early life seizures$228,620
R21 · FY2018 · NS · contact PI
Core C: Neural & Behavioral Phenotyping$187,698
P30 · FY2018 · NS · contact PI
Colorado Neurological Sciences Academic Development Award (NSADA)$433,470
K12 · FY2017 · NS
Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS)$306,000
U10 · FY2017 · NS
Core C: Neural & Behavioral Phenotyping$191,278
P30 · FY2017 · NS · contact PI
Exploratory determination of the role of L-type calcium channels in mediating abnormal plasticity and behavior after early life seizures$189,880
R21 · FY2017 · NS · contact PI
Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS)$306,000
U10 · FY2016 · NS
Colorado Neurological Sciences Academic Development Award (NSADA)$292,580
K12 · FY2016 · NS
Core C: Neural & Behavioral Phenotyping$187,698
P30 · FY2016 · NS · contact PI
Molecular mechanisms linking early life seizures, autism and intellectual disabil$331,905
R01 · FY2015 · NS · contact PI
Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS)$306,000
U10 · FY2015 · NS
Colorado Neurological Sciences Academic Development Award (NSADA)$151,690
K12 · FY2015 · NS
Molecular mechanisms linking early life seizures, autism and intellectual disabil$326,289
R01 · FY2014 · NS · contact PI
Rocky Mountain Network for Neuroscience Clinical Studies (RMNNCS)$295,994
U10 · FY2014 · NS
Molecular mechanisms linking early life seizures, autism and intellectual disabil$313,576
R01 · FY2013 · NS · contact PI
Molecular mechanisms linking early life seizures, autism and intellectual disabil$333,473
R01 · FY2012 · NS · contact PI
Molecular mechanisms linking early life seizures, autism and intellectual disabil$332,369
R01 · FY2011 · NS · contact PI
Impact of early life seizures on glutamate receptors and synaptic function$187,380
K02 · FY2009 · NS · contact PI
Impact of early life seizures on glutamate receptors and synaptic function$187,380
K02 · FY2008 · NS · contact PI
Impact of early life seizures on glutamate receptors and synaptic function$187,380
K02 · FY2007 · NS · contact PI
Impact of Early-Life Seizures on Synaptic Plasticity$130,680
K08 · FY2005 · NS
Impact of Early-Life Seizures on Synaptic Plasticity$130,680
K08 · FY2004 · NS
Impact of Early-Life Seizures on Synaptic Plasticity$130,680
K08 · FY2003 · NS
Impact of Early-Life Seizures on Synaptic Plasticity$130,680
K08 · FY2002 · NS
Impact of Early-Life Seizures on Synaptic Plasticity$126,575
K08 · FY2001 · NS